Advertisement

 

 

Sodium-glucose cotransporter-2 inhibitors: Expanding oral treatment options for type 2 diabetes mellitus.

Sodium-glucose cotransporter-2 inhibitors: Expanding oral treatment options for type 2 diabetes mellitus.
Author Information (click to view)

Ashjian E, Tingen J,


Ashjian E, Tingen J, (click to view)

Ashjian E, Tingen J,

Advertisement

The Nurse practitioner 42(4) 8-15 doi 10.1097/01.NPR.0000513336.46697.77
Abstract

The number of patients with type 2 diabetes mellitus (T2DM) continues to increase in the United States. Glycemic control among patients with diabetes is important to prevent future complications, including microvascular and macrovascular disease. A novel class of medications, sodium-glucose cotransporter-2 inhibitors, presents an additional oral treatment option for patients with T2DM.

Submit a Comment

Your email address will not be published. Required fields are marked *

two × 2 =

[ HIDE/SHOW ]